A citizen petition can ask FDA to examine a concern without proving the requested action is warranted. That distinction matters to patients and applicants alike. In the final rule published November 8, 2016, qualifying petitions do not justify delaying approval unless FDA determines that delay is necessary to protect public health. The rule takes effect January 9, 2017. [2016-26912][2011-33622]

The January 3, 2012 proposal described this balance for pending abbreviated new drug applications and the 505(b)(2) pathway. It paired a written petition requirement with an agency public-health judgment. Our ethical reading is that the opportunity to raise concerns and the responsibility to assess them are different obligations; neither deserves to disappear merely because the other exists. [2016-26912][2011-33622]

The final rule’s qualifying scope also includes certain section 351(k) biologics applications. Its response language for section 505(q) petitions refers to 150 days after receipt, rather than the older proposal’s 180-day framework. The clock concerns a petition response, not proof that the underlying medicine is safe or a commitment to approve its application. [2016-26912][2011-33622]

For this November 13 retrospective, fair treatment means resisting two shortcuts: calling every petitioner an obstructionist or treating every allegation as an established danger. Those are editorial cautions grounded in the rule’s separation of request and determination, not claims about particular participants. Both FDA records share one rulemaking chain. They describe a procedure for balancing obligations, without demonstrating patient outcomes or resolving the merits of any specific petition. [2016-26912][2011-33622]

Source documents

  1. Amendments to Regulations on Citizen Petitions, Petitions for Stay of Action, and Submission of Documents to Docketshttps://www.govinfo.gov/content/pkg/FR-2016-11-08/html/2016-26912.htm
  2. Amendments to Regulations on Citizen Petitions, Petitions for Stay of Action, and Submission of Documents to Docketshttps://www.govinfo.gov/content/pkg/FR-2012-01-03/html/2011-33622.htm